Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's disease
Biotech
UCB's tau drug flunks Alzheimer's trial days after Roche's exit
UCB looked past the primary endpoint miss and focused on other results that left it “deeply encouraged” by the trial.
Nick Paul Taylor
Nov 1, 2024 6:01am
Roche collects more data on blood tests for Alzheimer’s disease
Oct 31, 2024 12:32pm
Brain stimulation slows Alzheimer's disease in one-year trial
Oct 31, 2024 6:45am
Patient death prompts Roche to adjust Alzheimer's trial
Oct 30, 2024 11:40am
Coya shares data on IL-2 prospect in small Alzheimer's study
Oct 29, 2024 7:55am
Alzheimer's trials withheld brain injury risk disclosures: NYT
Oct 24, 2024 11:33am
